Clinical Trials Browser

Phase 1 × Urethral Neoplasms × Interferon alpha-2 × Clear all

NCT00082719 2015-05-14

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

Phase 1 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms